Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation

Nicotine and Tobacco Research

Volumn 14, Issue 8, 2012, Pages 993-997

  Spruell, Timothy ^a   Colavita, Guillaume ^a   Donegan, Tomas ^a   Egawhary, Marco ^a   Hurley, Michael ^a   Aveyard, Paul ^a   Johnstone, Elaine C ^b   Murphy, Michael F G ^b   Munafò, Marcus R ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4;

ADULT; ARTICLE; BEHAVIOR THERAPY; BLOOD LEVEL; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREATMENT DURATION;

ADULT; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84865085523     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr246     Document Type: Article

References (23)

1. Aveyard, P., Brown, K., Saunders, C., Alexander, A., Johnstone, E., Munafo, M. R., et al. (2007). Weekly versus basic smoking cessation support in primary care: A randomised controlled trial. Thorax, 62, 898-903. doi:10.1136/thx.2006.071837.
2. Aveyard, P., Johnson, C., Fillingham, S., Parsons, A., & Murphy, M. (2008). Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: Pragmatic randomised controlled trial. British Medical Journal, 336,1223-1227. doi:10.1136/bmj.39545.852616.BE.
3. Cahill, K., Stead, L. F., & Lancaster, T. (2011). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, (2), CD006103. doi:10.1002/14651858.CD006103.pub5.
4. Conti, D. V., Lee, W., Li, D., Liu, J., Van Den Berg, D., Thomas, P. D., et al. (2008). Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics, 17, 2834-2848. doi:10.1093/hmg/ddn181.
5. David, S. P., Johnstone, E. C., Churchman, M., Aveyard, P., Murphy, M. F., & Munafo, M. R. (2011). Pharmacogenetics of smoking cessation in general practice: Results from the patch II and patch in practice trials. Nicotine & Tobacco Research, 13, 157-167. doi:10.1093/ntr/ntq246.
6. Ehringer, M. A., Clegg, H. V., Collins, A. C., Corley, R. P., Crowley, T., Hewitt, J. K., et al. (2007). Association of the neu-ronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 144B, 596-604. doi:10.1002/ajmg.b.30464.
7. Etter, J. F., Hoda, J. C., Perroud, N., Munafo, M., Buresi, C. Duret, C., et al. (2009). Association of genes coding for the alpha-4, alpha-5, beta-2 andbeta-3 subunits of nicotinic receptors with cigarette smoking and nicotine dependence. Addictive Behaviors, 34, 772-775. doi:10.1016/j.addbeh.2009.05.010.
8. Feng, Y., Niu, T., Xing, H., Xu, X., Chen, C., Peng, S., et al. (2004). A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. American Journal of Human Genetics, 75, 112-121. doi:10.1086/422194.
9. Grottick, A. J., Trube, G., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., et al. (2000). Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. Journal of Pharmacology and Experimental Therapeutics, 294, 1112-1119. Retrieved from http://jpet.aspetjournals.org/.
10. Hutchison, K. E., Allen, D. L., Filbey, F. M., Jepson, C., Lerman, C. Benowitz, N. L., et al. (2007). CHRNA4 and tobacco dependence: From gene regulation to treatment outcome. Archives of General Psychiatry, 64, 1078-1086. doi:10.1001/archpsyc.64.9.1078.
11. Johnstone, E. C., Elliot, K. M., David, S. P., Murphy, M. F., Walton, R. T., & Munafo, M. R. (2007). Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology, Biomarkers, and Prevention, 16, 1065-1069. doi:16/6/1065[pii]10.1158/1055-9965.EPI-06-0936.
12. Kalamida, D., Poulas, K., Avramopoulou, V., Fostieri, E., Lagoumintzis, G., Lazaridis, K., et al. (2007). Muscle andneuro-nal nicotinic acetylcholine receptors. Structure, function and pathogenicity. FEBS Journal, 274, 3799-3845. doi:10.1111/j.1742-4658.2007.05935.x.
13. Koob, G. F. (1992). Neural mechanisms of drug reinforcement. Annals of the New York Academy of Sciences, 654, 171-191. doi:10.1111/j.1749-6632.1992.tb25966.x.
14. Li, M. D., Beuten, J., Ma, J. Z., Payne, T. J., Lou, X. Y., Garcia, V., et al. (2005). Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Human Molecular Genetics, 14, 1211-1219. doi:10.1093/hmg/ddi132.
15. Munafo, M. R., Freathy, R. M., Ring, S. M., St Pourcain, B., & Smith, G. D. (2011). Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women. Nicotine & Tobacco Research, 13, 55-63. doi:10.1093/ntr/ntq209.
16. Munafo, M. R., Johnstone, E. C., Guo, B., Murphy, M. F., & Aveyard, P. (2008). Association of COMT Val108/158Met genotype with smoking cessation. Pharmacogenetics and Genomics, 18, 121-128. doi:10.1097/FPC.0b013e3282f44daa01213011-200802000-00005[pii].
17. Munafo, M. R., Johnstone, E. C., Walther, D., Uhl, G. R., Murphy, M. F., & Aveyard, P. (2011). CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine & Tobacco Research, 13, 982-988. doi:ntr106[pii]10.1093/ntr/ntr106.
18. Perkins, K. A., Lerman, C., Mercincavage, M., Fonte, C. A., & Briski, J. L. (2009). Nicotinic acetylcholine receptor beta2 sub-unit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch. Cancer Epidemiology, Biomarkers, and Prevention, 18,2608-2612. doi:10.1158/1055-9965.EPI-09-0166.
19. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & Baker, T. B. (2003). Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology, 112,3-13.
20. Polosa, R., & Benowitz, N. L. (2011). Treatment of nicotine addiction: Present therapeutic options and pipeline developments. Trends in Pharmacological Sciences, 32, 281-289. doi:10.1016/j.tips.2010.12.008.
21. Silverman, M. A., Neale, M. C., Sullivan, P. F., Harris-Kerr, C. Wormley, B., Sadek, H., et al. (2000). Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor p2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. American Journal of Medical Genetics, 96, 646-653. doi:10.1002/1096-8628(20001009)96.
22. Weiss, R. B., Baker, T. B., Cannon, D. S., von Niederhausern, A., Dunn, D. M., Matsunami, N., et al. (2008). A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genetics, 4, e1000125. doi:10.1371/journal.pgen.1000125.
23. West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., et al. (2011). Placebo controlled trial of cytisine for smoking cessation. New England Journal of Medicine, 365, 1193-1200.